Welcome We address unmet medical needs to improve patients' prognosis and quality of life News BIGBEAR Pharmaceutical announces the approval of Binimetinib and Encorafenib in Laos See all news Our Products ENASIDX (Enasidenib) 50mg See all products ENASIDX (Enasidenib) 50mg ELTROMDX (Eltrombopag) 50mg CAPIVADX (Capivasertib) 200 mg CAPIVADX (Capivasertib) 160mg PONADX (Ponatinib) 15mg/45mg BRIGADX (Brigatinib) 90 mg / 180 mg RITEDX (Ritlecitinib) ASIDX (Axitinib)
中文
